Menu
GeneBe

NPC1

NPC intracellular cholesterol transporter 1, the group of Solute carrier family 65, NPC-type cholesterol transporters

Basic information

Region (hg38): 18:23506183-23586506

Links

ENSG00000141458NCBI:4864OMIM:607623HGNC:7897Uniprot:O15118AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Strong), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Strong), mode of inheritance: AR
  • Niemann-Pick disease type C, severe perinatal form (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, severe early infantile neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, late infantile neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, juvenile neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease type C, adult neurologic onset (Supportive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR
  • Niemann-Pick disease, type C1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Niemann-Pick disease, type C1; Niemann-Pick disease, type DARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Gastrointestinal; Neurologic; Ophthalmologic3865225; 3378364; 9211849; 9245994; 9634529; 9512307; 10361985; 10480349; 11182931; 12555942; 12408188; 15596783; 12955717; 15465421; 15465428; 16098014; 17497724; 17689147; 20301473; 19206179; 20484681; 32033912

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NPC1 gene.

  • Niemann-Pick disease, type C1 (1956 variants)
  • not provided (423 variants)
  • not specified (99 variants)
  • Inborn genetic diseases (92 variants)
  • Niemann-Pick disease, type C (78 variants)
  • NPC1-related condition (23 variants)
  • Niemann-Pick disease, type C1, juvenile form (3 variants)
  • Sphingomyelin/cholesterol lipidosis (3 variants)
  • Abnormality of metabolism/homeostasis (2 variants)
  • Dystonic disorder (2 variants)
  • See cases (2 variants)
  • 6 conditions (2 variants)
  • Capillary hemangioma (1 variants)
  • Seizure;Intellectual disability (1 variants)
  • Niemann-Pick disease, type D (1 variants)
  • Niemann-Pick disease, type C1, adult form (1 variants)
  • Niemann-Pick disease, type C2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPC1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
476
clinvar
3
clinvar
487
missense
34
clinvar
112
clinvar
446
clinvar
10
clinvar
6
clinvar
608
nonsense
30
clinvar
46
clinvar
76
start loss
2
clinvar
2
frameshift
110
clinvar
72
clinvar
4
clinvar
186
inframe indel
1
clinvar
8
clinvar
10
clinvar
19
splice donor/acceptor (+/-2bp)
17
clinvar
41
clinvar
1
clinvar
59
splice region
1
39
98
6
144
non coding
2
clinvar
29
clinvar
326
clinvar
45
clinvar
402
Total 192 283 498 812 54

Highest pathogenic variant AF is 0.000223

Variants in NPC1

This is a list of pathogenic ClinVar variants found in the NPC1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-23515960-G-A Benign (Jul 15, 2018)786337
18-23515989-A-G not specified Uncertain significance (Sep 17, 2021)3154773
18-23516323-G-T not specified Uncertain significance (Aug 10, 2021)3154774
18-23516432-G-A Likely benign (Jul 15, 2018)734642
18-23518925-A-G not specified Uncertain significance (Jul 20, 2021)3154776
18-23526674-A-C Benign (Apr 09, 2018)730421
18-23527835-C-G Benign (Jun 13, 2018)778149
18-23527897-C-T not specified Uncertain significance (Sep 01, 2021)3154770
18-23529669-T-C not specified Uncertain significance (Nov 08, 2021)3154772
18-23530033-C-T Benign (Mar 29, 2018)781357
18-23531484-G-A Niemann-Pick disease, type C1 Uncertain significance (Jan 12, 2018)891595
18-23531702-T-C Niemann-Pick disease, type C1 Uncertain significance (Jan 12, 2018)326239
18-23531708-C-A Niemann-Pick disease, type C1 Uncertain significance (Jan 13, 2018)891596
18-23531716-G-GT Niemann-Pick disease, type C Uncertain significance (Jun 14, 2016)326240
18-23531853-C-T Niemann-Pick disease, type C Uncertain significance (Jun 14, 2016)326241
18-23531868-A-T Niemann-Pick disease, type C1 Uncertain significance (Jan 12, 2018)326242
18-23531874-T-G Niemann-Pick disease, type C1 Uncertain significance (Jan 13, 2018)891597
18-23531875-G-A Niemann-Pick disease, type C1 Uncertain significance (Mar 16, 2018)891598
18-23531886-CCTTTACA-C Niemann-Pick disease, type C Conflicting classifications of pathogenicity (Jul 01, 2023)326243
18-23532000-G-A Niemann-Pick disease, type C1 Uncertain significance (Jan 12, 2018)326244
18-23532011-G-T Niemann-Pick disease, type C1 Uncertain significance (Jan 12, 2018)326245
18-23532038-A-G Niemann-Pick disease, type C1 Benign/Likely benign (Jul 14, 2018)326246
18-23532041-G-A Niemann-Pick disease, type C1 Uncertain significance (Jan 13, 2018)891853
18-23532073-A-C Niemann-Pick disease, type C1 Uncertain significance (Jan 13, 2018)891854
18-23532093-A-C Niemann-Pick disease, type C1 Uncertain significance (Jan 13, 2018)326247

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NPC1protein_codingprotein_codingENST00000269228 2580715
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000006541.001256550931257480.000370
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.096377190.8850.00004358401
Missense in Polyphen166238.130.69712755
Synonymous-1.073142911.080.00002012503
Loss of Function4.842162.20.3370.00000332715

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005110.000510
Ashkenazi Jewish0.0007940.000794
East Asian0.0002730.000272
Finnish0.0005590.000554
European (Non-Finnish)0.0004050.000404
Middle Eastern0.0002730.000272
South Asian0.0002940.000294
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Intracellular cholesterol transporter which acts in concert with NPC2 and plays an important role in the egress of cholesterol from the endosomal/lysosomal compartment (PubMed:9211849, PubMed:9927649, PubMed:10821832, PubMed:18772377, PubMed:27238017, PubMed:12554680). Unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes is transferred by NPC2 to the cholesterol- binding pocket in the N-terminal domain of NPC1 (PubMed:9211849, PubMed:9927649, PubMed:18772377, PubMed:19563754, PubMed:27238017, PubMed:28784760). Cholesterol binds to NPC1 with the hydroxyl group buried in the binding pocket (PubMed:19563754). Binds oxysterol with higher affinity than cholesterol. May play a role in vesicular trafficking in glia, a process that may be crucial for maintaining the structural and functional integrity of nerve terminals (Probable). {ECO:0000269|PubMed:10821832, ECO:0000269|PubMed:12554680, ECO:0000269|PubMed:18772377, ECO:0000269|PubMed:19563754, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:28784760, ECO:0000269|PubMed:9211849, ECO:0000269|PubMed:9927649, ECO:0000305}.;
Disease
DISEASE: Niemann-Pick disease C1 (NPC1) [MIM:257220]: A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C1 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood. An allelic variant of Niemann-Pick disease type C1 is found in people with Nova Scotia ancestry. Patients with the Nova Scotian clinical variant are less severely affected. {ECO:0000269|PubMed:10480349, ECO:0000269|PubMed:10521290, ECO:0000269|PubMed:10521297, ECO:0000269|PubMed:11182931, ECO:0000269|PubMed:11333381, ECO:0000269|PubMed:11349231, ECO:0000269|PubMed:11479732, ECO:0000269|PubMed:11545687, ECO:0000269|PubMed:11754101, ECO:0000269|PubMed:12401890, ECO:0000269|PubMed:12408188, ECO:0000269|PubMed:12554680, ECO:0000269|PubMed:12955717, ECO:0000269|PubMed:15774455, ECO:0000269|PubMed:16098014, ECO:0000269|PubMed:16126423, ECO:0000269|PubMed:16802107, ECO:0000269|PubMed:27238017, ECO:0000269|PubMed:9211849, ECO:0000269|PubMed:9634529}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);Irinotecan Pathway;Ebola Virus Pathway on Host;Ebola Virus Pathway on Host;LDL clearance;Plasma lipoprotein clearance;Transport of small molecules;C21-steroid hormone biosynthesis and metabolism;Plasma lipoprotein assembly, remodeling, and clearance (Consensus)

Recessive Scores

pRec
0.230

Intolerance Scores

loftool
0.0695
rvis_EVS
-0.05
rvis_percentile_EVS
50.02

Haploinsufficiency Scores

pHI
0.197
hipred
Y
hipred_score
0.554
ghis
0.445

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.623

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Npc1
Phenotype
reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); taste/olfaction phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
npc1
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
protein glycosylation;endocytosis;autophagy;lysosomal transport;adult walking behavior;cholesterol metabolic process;bile acid metabolic process;negative regulation of macroautophagy;cholesterol transport;membrane raft organization;intracellular cholesterol transport;cholesterol efflux;low-density lipoprotein particle clearance;response to drug;cholesterol homeostasis;response to cadmium ion;viral entry into host cell;negative regulation of cell death;cellular response to steroid hormone stimulus;cellular response to low-density lipoprotein particle stimulus;establishment of protein localization to membrane
Cellular component
extracellular region;nuclear envelope;lysosome;lysosomal membrane;endoplasmic reticulum;Golgi apparatus;integral component of plasma membrane;membrane;integral component of membrane;late endosome membrane;membrane raft;perinuclear region of cytoplasm;extracellular exosome;integral component of lysosomal membrane
Molecular function
virus receptor activity;transmembrane signaling receptor activity;protein binding;sterol transporter activity;cholesterol binding;signaling receptor activity